NextStep is a $50M seed-stage pediatrics-focused
healthcare venture fund with impact.
Our thesis is that due to a perfect storm of factors, pediatrics have become a viable investment space. We see a double bottom line opportunity to balance impact with generating significant investment returns. We invest in transformational companies that have been made possible through new breakthroughs in science and technology, including gene & stem cell therapies, multiomics, AI/machine learning, wearables and digital health. We seek investment returns through a portfolio constructed of diagnostics, devices, digital health, drugs and other therapies, which enables some quicker successes while also investing in companies with large exit potential.
Our team at NextStep has the right mix of investment, operational, research, and technical experience needed to identify transformational companies that represent viable businesses. Our team’s technical experience spans pediatrics research, pediatric surgery, bioengineering, drug discovery & drug development, computer science and AI/machine learning. We have extensive experience developing first-in-class solutions in a variety of fields. We have significant operational experience in venture capital, entrepreneurship and early-stage company building.
We have a well-curated network for deal sourcing, due diligence, and post-investment venture growth. We are headquartered in the San Francisco Bay Area, California, and are supported by a stellar scientific advisory Board, with members of our advisory team spanning leading medical research institutes and successful companies around the US.